News

Providing clinical development and vaccine services.

CMO will increase floor space at its Scotland-based site by 20%.

Strep bacteria’s tiny tentacle-like projections hold body’s natural antibiotics at bay, allowing the pathogens to spread unimpeded.

Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.

Researchers from Umeå University and University of Gothenburg have identified a molecular switch – MYSM1 – that can suppress such an overreaction and avoid inflammation.

Although the research was done in mice, the findings have possible implications for bone marrow transplants, more properly called hematopoietic stem cell transplants, in humans.

Pivotal study to evaluate Incyte’s IDO1 inhibitor in combination with Merck’s anti-PD-1 therapy in patients with advanced or metastatic melanoma.

Medium term prospects for contract services remain positive (both developed and emerging markets), despite fragmented biosimilar regulation and GDUFA fees.

Collaboration to study potential novel T-cell-based immuno-oncology therapies.

Acquisition will deliver contribution to 2015 financial results.